user avatar
David Sher
@DavidSherMD
"Ultimately, the secret of quality is love. You have to love your patient, you to have to love your profession, you have to love your G-d." Avedis Donabedian
Dallas, TX
Joined April 2019
Posts
  • user avatar
    I would like to recognize the professionalism and bravery of all of the radiation therapists treating patients despite the constant risks of #COVID19 exposure. They are under-appreciated heroes! @UTSW_RadOnc @E_T_TweetHome @ASTRO_org @subatomicdoc
  • user avatar
    Thrilled to see our INRT-AIR trial out in press! In this phase II study, we **eliminated** elective nodal irradiation for patients with HSNCC treated with definitive RT/CRT. aacrjournals.org/clincancerres/…
  • user avatar
    Absolutely remarkable RCT on weekly adaptive radiotherapy in oropharynx, showing *no* difference between the arms. Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Head and Neck Cancer
  • user avatar
    Performed a H&N adaptive fraction today using our new HyperSight on Ethos... The CBCT is effectively indistinguishable from the simulation CT... Success of adaptive radiotherapy hinges on visualization of the targets and OARs. Impressive!
  • user avatar
    So disappointing that weather prevented our presentation of the @UTSW_RadOnc phase II LT-SABR trial (yes, pronounced "light saber") for early-stage glottic larynx cancer at #HNCS22. Below are the slides!
  • user avatar
    H&N contouring tip. There are no lymph nodes inside the submandibular gland (in contrast to the parotid). So when contouring level IB, do not include the gland in your volume. It will unnecessarily increase your oral cavity dose (for non-oral cavity primaries).
  • user avatar
    This rental car was meant for me! (a little H&N rad onc humor…)
  • user avatar
    We had a very exciting week here @UTSW_RadOnc as we finished treating our last patient on the H&N DARTBOARD trial! This randomized ph II study is comparing daily adaptive RT and near-marginless treatment (1 mm PTV) with standard IGRT using CBCT-based ART (Ethos) for H&N SqCC.
  • user avatar
    Perhaps I’m tipping over a sacred (H&N contouring) cow, but… Why do we need 5 mm around the GTV for CTV70? Let’s have PTV70 = GTV70 plus setup error. Use a lower dose CTV for microscopic dz. Why? Almost all recurrences are directly in-field (1/2)
  • user avatar
    My 9 yo asked “what is saliva?” and got more than he bargained for. Now he has a healthy respect for the submandibular glands and is finally ready to contour some OARs.
  • user avatar
    This trial is insane in every good way imaginable. Insanely innovative, insanely different from standard-of-care, insanely successful. A few thoughts below.
    Practice changing clinical trial by @imrtlee @xrtGenomics @MSK_RadOnc @MSKCancerCenter and the entire HN group. Results from this study again demonstrated the importance of biology driven de-escalation. One size does not fit all. @DavidSherMD @DanielMaMD @henson_md @YaoCMKL
  • user avatar
    How can it be 2021 and I need to write a letter of medical necessity to use IMRT for postop oropharynx?
  • user avatar
    Very happy for @DominicMoonMD to see his HYPORT study out in @IJROBP. @UTSW_RadOnc phase I trial of hypofractionated adjuvant RT for resected HNSCC: 3 weeks of treatment! 46.5 Gy/15 fx then 44.4 Gy/12 fx. 6 pts/cohort. redjournal.org/article/S0360-…
  • user avatar
    We are hiring a H&N radiation oncologist! Our facility has fantastic technologies that are ideal for H&N neck radiotherapy (CBCT- and MRI-based adaptive radiotherapy, MRI and soon-to-be PET sim, PET-linac etc etc), and we have a culture that encourages innovation. (1/2)
    We are seeking clinical radiation oncologists to join our GU, H&N, and GYN disease-oriented teams! To apply, scan the QR code below or visit direct link: bit.ly/3XIZkSa